Swiss Re’s HCA Healthcare HCA Stock Holding History

Swiss Re’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$154K	Buy	+395	New	+$167K	0.01%	166

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Swiss Re's HCA Position: Q2 2026 in Review

Swiss Re opened a new position in HCA Healthcare (HCA) in Q2 2026: 395 shares worth $154K. The stake represents 0.01% of the portfolio and ranks #166 among its holdings.

1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

Swiss Re held 395 shares of HCA Healthcare worth $154K as of Q2 2026.
HCA Healthcare was a new Swiss Re position in Q2 2026.
HCA Healthcare made up 0.01% of Swiss Re's portfolio in Q2 2026, its #166 holding.
1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Swiss Re's 13F filing for Q2 2026, filed 11 Aug 2026.